Related Experiment Video
Updated: May 25, 2026

Methods to Discover Alternative Promoter Usage and Transcriptional Regulation of Murine Bcrp1
Published on: May 27, 2016
Null alleles of ABCG2 encoding the breast cancer resistance protein define the new blood group system Junior
Carole Saison1, Virginie Helias, Bryan A Ballif
1National Institute of Blood Transfusion (INTS), Paris, France.
Abstract:
The breast cancer resistance protein, also known as ABCG2, is one of the most highly studied ATP-binding cassette (ABC) transporters because of its ability to confer multidrug resistance. The lack of information on the physiological role of ABCG2 in humans severely limits cancer chemotherapeutic approaches targeting this transporter. We report here that ABCG2 comprises the molecular basis of a new blood group system (Junior, Jr) and that individuals of the Jr(a-) blood type have inherited two null alleles of ABCG2. We identified five frameshift and three nonsense mutations in ABCG2. We also show that the prevalence of the Jr(a-) blood type in the Japanese and European Gypsy populations is related to the p.Gln126* and p.Arg236* protein alterations, respectively. The identification of ABCG2(-/-) (Jr(a-)) individuals who appear phenotypically normal is an essential step toward targeting ABCG2 in cancer and also in understanding the physiological and pharmacological roles of this promiscuous transporter in humans.
Insights
The breast cancer resistance protein ABCG2 is identified as the molecular basis for the Junior blood group system. Individuals with the Jr(a-) blood type lack functional ABCG2, offering insights into cancer drug targeting.
Area of Science:
- Biochemistry
- Genetics
- Immunology
Background:
- The breast cancer resistance protein ABCG2 (ATP-binding cassette transporter G2) is crucial for multidrug resistance.
- Limited knowledge of ABCG2's physiological role hinders targeted cancer chemotherapy.
- ABCG2's function in normal human physiology remains largely uncharacterized.
Purpose of the Study:
- To elucidate the physiological role of ABCG2 in humans.
- To identify the molecular basis of the Junior (Jr) blood group system.
- To explore the implications of ABCG2 null alleles for cancer therapy.
Main Methods:
- Genetic analysis of individuals with the Jr(a-) blood type.
- Identification and characterization of mutations in the ABCG2 gene.
- Population-based studies to determine the prevalence of specific ABCG2 alterations.
Main Results:
- ABCG2 was identified as the molecular foundation of the Junior blood group system.
- Individuals with the Jr(a-) blood type possess two non-functional ABCG2 alleles.
- Five frameshift and three nonsense mutations in ABCG2 were identified.
- Specific ABCG2 mutations (p.Gln126* and p.Arg236*) correlate with Jr(a-) prevalence in Japanese and European Gypsy populations, respectively.
- ABCG2(-/-) (Jr(a-)) individuals exhibit normal phenotypes.
Conclusions:
- ABCG2 is essential for the Junior blood group.
- The identification of phenotypically normal ABCG2(-/-) individuals is critical for developing targeted cancer therapies.
- Understanding ABCG2's physiological and pharmacological roles is vital for human health.
Related Concept Videos
The ABO Blood Group
Antigens in the ABO Blood Group System
Antigens are substances that can trigger an immune response, leading to the production of antibodies. In the ABO blood group system,...
Blood Types
ABO blood group
ABO antigens are glycoproteins encoded by genes present on...
Rh Blood Group
Blood Typing
Antigens are protein molecules that reside on the surface of red blood cells (RBCs). The ABO and Rh blood typing systems target antigens A,...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
ABC Transporters: Exporter

